Carboprost Tromethamine

Especificaciones

58551-69-2Número CAS

638-806-5Número CE

2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acidNombre IUPAC

C25H47NO8Fórmula química

489.6 g/molPeso molecular

CARBOPROST TROMETHAMINE; 58551-69-2; Hemabate; carboprost trometamol; U-32921E; U-32,921E; U4526F86FJ; PROSTIN/15M; Carboprost tromethamine salt; DTXSID601015618; (15S)-15-Methylprostaglandin F(sub 2alpha) tromethamine; 15-methylprostaglandin F2alpha-tromethamine; (15S)-15-Methylprostaglandin F2alpha tromethamine; CHEBI:3404; RefChem:56814; DTXCID701473855; (15S)-9a, 11a, 15-Trihydroxy-15-methyl-prosta-cis-5, trans-13-dienoic Acid Tromethamine Salt; 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z)-7-((1R,2R,3S,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl)hept-5-enoate; Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-,(5Z,9-alpha,11-alpha,13E,15S)-, compound with 2-Amino-2-(hydroxymethyl)-1,3-propanediol(1:1); (15S)-15-methyl-PGF2alpha tromethamine salt; 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13E,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate; 15(S)-15-methyl-PGF2alpha tromethamine salt; 15(S)-15-methylprostaglandin F2alpha tromethamine; Carboprost Trometanol; Carboprost (tromethamine); 2-Amino-2-(hydroxymethyl)propane-1,3-diol (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl)hept-5-enoic acid; 2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid; 15-Methyl prostaglandin F2alpha; (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(3S)-3-hydroxy-3-methyl-1-octenyl)cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1); 2-Amino-2-(hydroxymethyl)propane-1,3-diol (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl)hept-5-enoate; Prostin / 15M; UNII-U4526F86FJ; Carboprost tromethamine [USAN]; C25H47NO8; Hemabate (TN); (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3S)-3-hydroxy-3-methyl-1-octenyl]cyclopentyl]-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1); Carboprost trometamol; 2-Amino-2-(hydroxymethyl)propane-1,3-diol (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoate; (15S)-15-methyl-PGF2; Prostin/15; Carboprost tromethamine [USAN:USP]; U 32921E; 15-Methyl PGF2 alpha; Carboprost trometamol CRS; 15(S)15-Methyl pgf2-alpha tromethamine salt; SCHEMBL433085; 15(S)15-Methyl prostaglandin F2-alpha tromethamine; Carboprost tromethamine (USP); orb1219528; orb1308495; CHEMBL1237105; HY-A0195R; WLZ5393; UMMADZJLZAPZAW-XOWPVRJPSA-N; GLXC-15346; HY-A0195; MSK15029; Carboprost (tromethamine) (Standard); EBC-27222; CARBOPROST TROMETAMOL [MART.]; AKOS037435222; CARBOPROST TROMETAMOL [WHO-DD]; FC34897; CARBOPROST TROMETHAMINE [USP-RS]; CARBOPROST TROMETHAMINE SALT [MI]; DA-62058; CARBOPROST TROMETAMOL [EP MONOGRAPH]; CARBOPROST TROMETHAMINE [ORANGE BOOK]; CS-0017541; CARBOPROST TROMETHAMINE [USP MONOGRAPH]; D00682; E78557; T14865; EN300-21740207; Q18578732; (15S)-15-METHYLPROSTAGLANDIN F(SUB 2.ALPHA.) TROMETHAMINE; (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-3-methyloct-1-en-1-yl]cyclopentyl]hept-5-enoic acid; 2-amino-2-(hydroxymethyl)propane-1,3-diol; (5Z,13E,15S)-9alpha,11alpha,15-Trihydroxy-15-methylprosta-5,13-dien-1-oic acid--2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1); (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((S,E)-3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl)hept-5-enoate tris(hydroxymethyl)aminomethane salt; 2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid; PROSTA-5,13-DIEN-1-OIC ACID, 9,11,15-TRIHYDROXY-15-METHYL-, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-, COMPOUND WITH 2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL (1:1)Sinónimos